Phase 1/2 Study of PYX-201 in Combination with Pembrolizumab in Advanced Solid Tumors
PYX-201-102
Phase 2 other active
Quick answer
Phase 1/2 Study of PYX-201 in Combination with Pembrolizumab in Advanced Solid Tumors for Advanced Solid Tumors is a Phase 2 program (other) at Pyxis Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pyxis Oncology
- Indication
- Advanced Solid Tumors
- Phase
- Phase 2
- Modality
- other
- Status
- active